{"id":"https://openalex.org/W1986203997","doi":"https://doi.org/10.1158/1538-7445.am2011-5504","title":"Abstract 5504: FANCF over expression correlates with selected resistance to topoisomerase II inhibitors independent of other FA/BRCA DNA repair core complex constituents","display_name":"Abstract 5504: FANCF over expression correlates with selected resistance to topoisomerase II inhibitors independent of other FA/BRCA DNA repair core complex constituents","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W1986203997","doi":"https://doi.org/10.1158/1538-7445.am2011-5504","mag":"1986203997"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-5504","doi":"https://doi.org/10.1158/1538-7445.am2011-5504","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5504","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103509083","display_name":"Liang Nong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Nong","raw_affiliation_strings":["1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110324556","display_name":"Linda Mathews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Mathews","raw_affiliation_strings":["1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103061547","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0001-9417-2599","observed_orcids":["https://orcid.org/0000-0001-9417-2599"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William S. Dalton","raw_affiliation_strings":["1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032654984","display_name":"Danielle N. Yarde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Yarde","raw_affiliation_strings":["1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"5504","last_page":"5504"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fanconi-anemia","display_name":"Fanconi anemia","score":0.5950000286102295},{"id":"https://openalex.org/keywords/fancf","display_name":"FANCF","score":0.9589999914169312},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/mitoxantrone-resistance","display_name":"mitoxantrone resistance","score":0.9290000200271606},{"id":"https://openalex.org/keywords/melphalan-resistance","display_name":"melphalan resistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8270000219345093},{"id":"https://openalex.org/keywords/fancd2","display_name":"FANCD2","score":0.5440000295639038},{"id":"https://openalex.org/keywords/fanci","display_name":"FANCI","score":0.9229999780654907},{"id":"https://openalex.org/keywords/monoubiquitination","display_name":"monoubiquitination","score":0.8050000071525574},{"id":"https://openalex.org/keywords/interstrand-crosslinks","display_name":"interstrand cross-links","score":0.734000027179718},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.5619999766349792},{"id":"https://openalex.org/keywords/gene-overexpression","display_name":"gene overexpression","score":0.5899999737739563},{"id":"https://openalex.org/keywords/rpmi-8226-cells","display_name":"RPMI 8226 cells","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2776653068","wikidata":"https://www.wikidata.org/wiki/Q17927069","display_name":"FANCD2","level":5,"score":0.864301323890686},{"id":"https://openalex.org/C2778993383","wikidata":"https://www.wikidata.org/wiki/Q17927056","display_name":"FANCA","level":5,"score":0.8058595657348633},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6616908311843872},{"id":"https://openalex.org/C2778124228","wikidata":"https://www.wikidata.org/wiki/Q845779","display_name":"Fanconi anemia","level":4,"score":0.6586499214172363},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6409890651702881},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.6221932768821716},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5450695753097534},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5368884205818176},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5302899479866028},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4808124303817749},{"id":"https://openalex.org/C2779309665","wikidata":"https://www.wikidata.org/wiki/Q17917256","display_name":"ERCC1","level":5,"score":0.4177594780921936},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4090993106365204},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.37702155113220215},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3452984094619751},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2555656433105469},{"id":"https://openalex.org/C104451858","wikidata":"https://www.wikidata.org/wiki/Q2714458","display_name":"Nucleotide excision repair","level":4,"score":0.12933248281478882}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-5504","doi":"https://doi.org/10.1158/1538-7445.am2011-5504","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5504","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980192386","https://openalex.org/W2576208143","https://openalex.org/W2094722256","https://openalex.org/W1968252950","https://openalex.org/W2015901442","https://openalex.org/W2584273423","https://openalex.org/W2281834701","https://openalex.org/W1979472043","https://openalex.org/W3045474526","https://openalex.org/W2189195545"],"abstract_inverted_index":{"Abstract":[0],"The":[1,70],"Fanconi":[2],"Anemia":[3],"(FA)/BRCA":[4],"DNA":[5,24,59,121,287,408],"repair":[6,11,122,411],"pathway":[7,38,62,76,153,386],"is":[8,77],"integral":[9],"in":[10,21,44,118,214,225,248,251,273,322,338,368,387,412],"of":[12,35,66,74,82,93,101,142,149,171,187,223,236,302,372,381,426,431],"the":[13,31,36,78,89,94,134,150,212,252,303,379,384,427,432],"interstrand":[14],"crosslinks":[15],"that":[16,30,279,294,364],"accumulate":[17],"during":[18],"replication":[19],"and":[20,84,112,116,126,136,144,164,204,220,228,244,254,262,345,350,359,383,395,402,410,415],"response":[22,61],"to":[23,40,175,283,336,354,392],"damaging":[25],"agents.":[26],"We":[27],"recently":[28],"demonstrated":[29,160,241,269,329],"constitutive":[32],"over":[33,169,340],"expression":[34,148,170,184,222,250,310],"FA/BRCA":[37,152,304,374,385],"contributes":[39],"selected":[41],"melphalan":[42],"resistance":[43,146,335,370,389],"two":[45],"isogenic":[46],"myeloma":[47],"cell":[48,138,231,256],"line":[49],"models.(Yarde":[50],"et":[51],"al":[52],"2009)":[53],"These":[54,276,361],"proteins":[55,398],"comprise":[56],"a":[57,98,161,242,270,292,330],"co-dependent":[58],"damage":[60,409],"involving":[63],"thirteen":[64],"loss":[65],"function":[67],"complementation":[68],"groups.":[69],"key":[71],"functional":[72],"event":[73],"this":[75,130],"interdependent":[79],"mono-ubiquitination":[80],"(Ub)":[81],"FANCD2":[83,115],"FANCI":[85],"(ID":[86],"complex)":[87],"by":[88,123],"E3":[90],"Ub-ligase":[91],"activity":[92],"FA":[95,103,397],"core":[96,189],"complex,":[97],"multimer":[99],"consisting":[100],"8":[102],"members":[104,154],"(FANCA,":[105],"B,":[106],"C,":[107],"E,":[108],"F,":[109],"G,":[110],"L":[111],"M).":[113],"Mono-Ub":[114],"FANCI,":[117],"turn,":[119],"facilitate":[120,313],"homologus":[124],"recombination":[125],"translesion":[127],"synthesis.":[128],"In":[129],"study,":[131],"we":[132,217,390],"screened":[133],"8226/Dox40":[135,229,255],"8226/MR20":[137],"lines":[139,232],"as":[140,352],"models":[141],"doxorubicin":[143,215,237,314,337,369,388],"mitoxantrone":[145],"for":[147,435],"12":[151],"with":[155],"quantitative":[156],"PCR":[157],"(qPCR).":[158],"QPCR":[159],"2.6":[162],"(p<0.05)":[163],"1.7":[165],"(p<0.05,":[166],"respectively)":[167],"fold":[168,246,334],"FANCF":[172,182,213,224,239,280,309,339,365,382,394],"mRNA":[173,183,219,249],"relative":[174],"drug":[176],"sensitive":[177,324],"RPMI8226":[178,323],"cells.":[179,326,417],"Interestingly,":[180],"elevated":[181],"was":[185],"independent":[186,301],"other":[188,373,396],"complex":[190],"constituents":[191],"(e.g.":[192],"Dox40:":[193],"FANCA:":[194],"0.90,":[195,197],"B:":[196],"C:":[198],"0.89,":[199],"E:":[200],"1.1,":[201,203],"G":[202],"L:":[205],"1.4-fold":[206],"RMPI8226":[207],"(p>0.05)).":[208],"To":[209,306,376],"further":[210],"characterize":[211,378],"resistance,":[216,315],"examined":[218],"protein":[221,274],"RPMI8226,":[226],"8226/Dox6":[227,253,414],"MM":[230,325],"(representing":[233],"progressive":[234],"levels":[235],"resistance).":[238],"qPCR":[240],"2":[243,333],"4.7":[245],"increased":[247],"lines,":[257],"respectively":[258],"(p":[259],"=":[260,264],"0.103":[261],"p":[263],"0.034).":[265],"Western":[266],"blot":[267],"analysis":[268],"parallel":[271],"increase":[272],"expression.":[275],"observations":[277],"suggest":[278,363],"may":[281,312,366],"contribute":[282],"topoisomerase":[284],"II":[285],"inhibitor-mediated":[286],"double":[288],"strand":[289],"break":[290],"repair,":[291],"process":[293],"primarily":[295],"involves":[296],"non-homologous":[297],"end":[298],"joining":[299],"(NHEJ)":[300],"pathway.":[305],"determine":[307],"if":[308],"alone":[311],"pQCXIP-control":[316],"or":[317],"pQCXIP-FANCF":[318],"constructs":[319],"were":[320],"expressed":[321],"MTT":[327],"assays":[328],"greater":[331],"than":[332],"expressing":[341],"cells":[342,356],"at":[343],"48":[344],"96":[346],"hours":[347],"(IC50:":[348],"3.26\u00d710\u22126":[349],"1.13\u00d710\u22128M)":[351],"compared":[353],"control":[355],"(1.33":[357],"x10\u22126":[358],"5.3\u00d710\u22129M).":[360],"results":[362],"participate":[367],"independently":[371],"members.":[375],"better":[377],"role":[380],"plan":[391],"target":[393],"using":[399],"lentivirus":[400],"shRNA":[401],"evaluate":[403],"doxorubicin-mediated":[404],"FANCD2-Ub,":[405],"foci":[406],"formation,":[407],"sensitive,":[413],"Dox40":[416],"Citation":[418],"Format:":[419],"{Authors}.":[420],"{Abstract":[421],"title}":[422],"[abstract].":[423],"In:":[424],"Proceedings":[425],"102nd":[428],"Annual":[429],"Meeting":[430],"American":[433],"Association":[434],"Cancer":[436,446],"Research;":[437],"2011":[438],"Apr":[439],"2-6;":[440],"Orlando,":[441],"FL.":[442],"Philadelphia":[443],"(PA):":[444],"AACR;":[445],"Res":[447],"2011;71(8":[448],"Suppl):Abstract":[449],"nr":[450],"5504.":[451],"doi:10.1158/1538-7445.AM2011-5504":[452]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}